NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: In a limited number of experiments, AGE-HSA has exhibited opposing results to CML-HSA, which may be explained by considering that different levels of NF-κB activation can affect the cellular activity in different and potentially opposing ways.